Anhui Anke BioTech Group Cash Flow-to-Debt Ratio
Anhui Anke BioTech Group cash flow-to-debt ratio. Anhui Anke BioTech Group (300009) has a Cash Flow-to-Debt Ratio of 0.32x as of September 2025, meaning its operating cash flow of CN¥240.51 Million could theoretically repay 0% of its total liabilities (CN¥755.64 Million) in one year. Check cash flow quality index of Anhui Anke BioTech Group to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Anhui Anke BioTech Group (2006–2025)
Cash flow-to-debt ratio of Anhui Anke BioTech Group from 2006 to 2025. Historical debt coverage capacity for Anhui Anke BioTech Group across 20 annual periods. Check cash flow reinvestment rate of Anhui Anke BioTech Group to assess the company's total reinvestment commitment from operating cash flow.
Anhui Anke BioTech Group Cash Flow-to-Debt Ratio by Year (2006–2025)
Anhui Anke BioTech Group cash flow-to-debt ratio by year from 2006 to 2025. Year-by-year debt coverage analysis for Anhui Anke BioTech Group. For the full cash flow conversion analysis, see 300009 cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 1.06x | CN¥863.22 Million | CN¥811.30 Million | ▲ +29.7% |
| 2024 | 0.82x | CN¥685.37 Million | CN¥835.41 Million | ▼ -12.3% |
| 2023 | 0.94x | CN¥952.97 Million | CN¥1.02 Billion | ▲ +14.5% |
| 2022 | 0.82x | CN¥698.98 Million | CN¥855.17 Million | ▲ +5.7% |
| 2021 | 0.77x | CN¥592.17 Million | CN¥765.52 Million | ▼ -0.1% |
| 2020 | 0.77x | CN¥464.80 Million | CN¥600.29 Million | ▲ +37.8% |
| 2019 | 0.56x | CN¥295.63 Million | CN¥526.19 Million | ▲ +0.8% |
| 2018 | 0.56x | CN¥287.49 Million | CN¥515.86 Million | ▼ -1.9% |
| 2017 | 0.57x | CN¥280.63 Million | CN¥493.73 Million | ▲ +18.7% |
| 2016 | 0.48x | CN¥258.01 Million | CN¥539.04 Million | ▼ -49.0% |
| 2015 | 0.94x | CN¥118.73 Million | CN¥126.48 Million | ▲ +22.7% |
| 2014 | 0.76x | CN¥108.68 Million | CN¥142.11 Million | ▲ +28.2% |
| 2013 | 0.60x | CN¥53.21 Million | CN¥89.21 Million | ▼ -19.2% |
| 2012 | 0.74x | CN¥53.80 Million | CN¥72.91 Million | ▲ +514.2% |
| 2011 | 0.12x | CN¥7.18 Million | CN¥59.77 Million | ▼ -83.0% |
| 2010 | 0.71x | CN¥47.43 Million | CN¥67.25 Million | ▼ -14.4% |
| 2009 | 0.82x | CN¥38.67 Million | CN¥46.95 Million | ▲ +135.1% |
| 2008 | 0.35x | CN¥26.04 Million | CN¥74.32 Million | ▼ -0.7% |
| 2007 | 0.35x | CN¥35.10 Million | CN¥99.46 Million | ▲ +23.4% |
| 2006 | 0.29x | CN¥29.66 Million | CN¥103.72 Million | — |